Enovix (NASDAQ:ENVX) Trading 5.8% Higher – Here’s What Happened

Enovix Co. (NASDAQ:ENVXGet Free Report)’s stock price traded up 5.8% on Thursday . The stock traded as high as $11.42 and last traded at $11.40. 2,675,972 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 8,937,021 shares. The stock had previously closed at $10.78.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. JPMorgan Chase & Co. dropped their price target on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $30.00 price target on shares of Enovix in a report on Wednesday, October 30th. Janney Montgomery Scott downgraded Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research note on Thursday, October 31st. Finally, Benchmark restated a “buy” rating and set a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.50.

Get Our Latest Report on Enovix

Enovix Stock Performance

The company has a market capitalization of $1.96 billion, a PE ratio of -6.90 and a beta of 1.86. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77. The stock’s fifty day simple moving average is $9.98 and its 200-day simple moving average is $11.02.

Enovix (NASDAQ:ENVXGet Free Report) last released its earnings results on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.03. The firm had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. During the same period in the prior year, the firm posted ($0.27) earnings per share. As a group, equities analysts predict that Enovix Co. will post -1.17 earnings per share for the current year.

Insider Buying and Selling

In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total transaction of $729,750.00. Following the transaction, the director now owns 99,497 shares of the company’s stock, valued at $968,105.81. This trade represents a 42.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 15.70% of the company’s stock.

Institutional Trading of Enovix

A number of institutional investors and hedge funds have recently made changes to their positions in ENVX. Rhumbline Advisers increased its stake in Enovix by 13.7% during the second quarter. Rhumbline Advisers now owns 221,966 shares of the company’s stock worth $3,432,000 after acquiring an additional 26,724 shares during the last quarter. Perennial Investment Advisors LLC grew its holdings in shares of Enovix by 99.7% during the 2nd quarter. Perennial Investment Advisors LLC now owns 36,200 shares of the company’s stock worth $560,000 after purchasing an additional 18,075 shares during the period. Mercer Global Advisors Inc. ADV acquired a new stake in Enovix during the 2nd quarter worth approximately $163,000. XTX Topco Ltd acquired a new position in Enovix during the second quarter valued at approximately $820,000. Finally, Sei Investments Co. acquired a new stake in shares of Enovix in the second quarter worth $555,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Further Reading

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.